BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Diagnosis
26 results:

  • 1. Diagnostic utility of lmo2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
    Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
    Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Human Germinal Center-associated lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell lymphoma.
    Koo M; Zhang J; Tan B; Kurzer J; Gratzinger D; Zhao S; Suarez C; Lossos IS; Warnke RA; Natkunam Y
    Am J Surg Pathol; 2022 May; 46(5):643-654. PubMed ID: 34907996
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A combination of lmo2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma.
    Liu Y; Bian T; Zhang Y; Zheng Y; Zhang J; Zhou X; Xie J
    Diagn Pathol; 2019 Sep; 14(1):100. PubMed ID: 31484540
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The accuracy of diagnosing Burkitt lymphoma in serous effusion specimen: A cytological-histological correlation with ancillary studies.
    Li J; Zhang W; Zhao S; Jiang Y; Liu W; Zhu X; Su X
    Cytopathology; 2019 Jul; 30(4):378-384. PubMed ID: 30983044
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential diagnosis of B-Cell Non-Hodgkin lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell lymphomas.
    Kunder CA; Roncador G; Advani RH; Gualco G; Bacchi CE; Sabile JM; Lossos IS; Nie K; Tibshirani RJ; Green MR; Alizadeh AA; Natkunam Y
    Am J Clin Pathol; 2017 Nov; 148(6):465-476. PubMed ID: 29140403
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic value of STMN1, lmo2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. lmo2 Is a Specific Marker of T-Lymphoblastic Leukemia/lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
    Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
    Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
    Tzankov A; Leu N; Muenst S; Juskevicius D; Klingbiel D; Mamot C; Dirnhofer S
    J Hematol Oncol; 2015 Jun; 8():70. PubMed ID: 26071053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The utility of IgM, CD21, HGAL and lmo2 in the diagnosis of pediatric follicular lymphoma.
    Karnik T; Ozawa MG; Lefterova M; Luna-Fineman S; Alvarez E; Link M; Zehnder JL; Arber DA; Ohgami RS
    Hum Pathol; 2015 Apr; 46(4):629-33. PubMed ID: 25701230
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and lmo2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunoarchitectural patterns of germinal center antigens including lmo2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
    Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
    Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HOX-mediated lmo2 expression in embryonic mesoderm is recapitulated in acute leukaemias.
    Calero-Nieto FJ; Joshi A; Bonadies N; Kinston S; Chan WI; Gudgin E; Pridans C; Landry JR; Kikuchi J; Huntly BJ; Gottgens B
    Oncogene; 2013 Nov; 32(48):5471-80. PubMed ID: 23708655
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Detection of LIM domain only 2 (lmo2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
    Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
    Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The efficacy of HGAL and lmo2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
    Younes SF; Beck AH; Ohgami RS; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2011 May; 135(5):697-708. PubMed ID: 21502424
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling.
    Loi TH; Campain A; Bryant A; Molloy TJ; Lutherborrow M; Turner J; Yang YH; Ma DD
    BMC Med Genomics; 2011 Mar; 4():27. PubMed ID: 21453471
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and lmo2 in the detection of the interfollicular and diffuse components.
    Younes SF; Beck AH; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Surg Pathol; 2010 Sep; 34(9):1266-76. PubMed ID: 20697248
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.